Click image for larger version  Name:	whf.png Views:	1 Size:	12.7 KB ID:	48313
Next steps for combating antimicrobial resistance - funding, prevention and research priorities

Westminster Health Forum and Westminster Food & Nutrition Forum Keynote Seminar

Morning, Wednesday, 6th February 2019

Central London

Book Online | Live Agenda |

The agenda includes keynote contributions from Professor Dame Sally Davies, Chief Medical Officer, Department of Health and Social Care (subject to diary); Professor Alan Johnson, Head of Surveillance, Antimicrobial Resistance Division, National Infection Service, Public Health England and Dr Manica Balasegaram, Executive Director, Global Antibiotic Research and Development Partnership.

New strategy

With an update to the Government’s AMR Strategy expected to be released soon, and to include a 20-year vision and five-year action plans, the agenda will assess priorities in the strategy and the way forward for delivery.

With NHS England committing to further action on AMR in the recently-publishedNHS Long Term Plan - and in light of the Health and Social Care Committee’s report into AMR, which calls for greater leadership from Government and coordination among departments - delegates will assess what further steps might be necessary to ensure continuedprogress is made.

Priorities for research

Planned sessions will look at the progress of research being conducted to strengthen efforts to tackle the spread of AMR and to develop new forms of treatment for drug resistant bacterial infections - including industry collaboration, funding for new medicines and the role of reimbursement models in encouraging drug development.

Attendees will also consider next steps for diagnostics being utilised to identify drug-resistant bacteria and support treatment decisions.

Funding research and development into prevention and new treatments

Further sessions will focus on the impact of new sources of funding in bringing new solutions, with: Prescribing in humans and animals

Delegates will examine the measures being taken by industry and healthcare professionals to encourage the responsible use of antibiotics in healthcare - with the need for responsible prescribing recently highlighted in the DHSC’s vision for prevention, with:
  • The Secretary of State for Health and Social Care announcing a review into overprescribing in the NHS, including looking into how the improved usage of data can help to address instances of overprescribing; and
  • The Veterinary Medicines Directorate reporting that sales ofantibiotics for use in food-producing animals are at their lowest since 1993, there will also be focus on progress towards reducing the use of antibiotics within farming and agriculture, looking at potential ways forward for developing a holistic approach to human, animal and environmental health.
International collaboration and the UK biological security strategy

There will also be discussion on the next steps for strengthening international collaboration on AMR, which is highlighted as a main strand of the UK biological security strategy - and follows £30m funding made available by the Government to support the global fight against AMR.

The agenda
  • Priorities from the AMR Strategy and meeting the 20-year vision;
  • Key issues for implementing the AMR Strategy - funding, prevention and aligning with the NHS Long Term Plan;
  • Engaging with clinicians to encourage the appropriate use of antibiotics;
  • Challenges for implementation - the role of CCGs, industry and the public;
  • Utilising diagnostics to reduce the risk posed by AMR;
  • Co-ordinating a global response to AMR;
  • Priorities for research - reimbursement frameworks, vaccinations and developing new treatments; and
  • Developing a holistic approach to tackle resistance - reducing the use of antibiotics in food and agriculture.

The draft agenda is copied below my signature, and a regularly updated version is available to download here. The seminar is supported by BD - Becton Dickinson and is organised on the basis of strict impartiality by the Westminster Health Forum and Westminster Food & Nutrition Forum. Follow us @WHFEvents @WFNFEvents for live updates.


We are delighted to be able to include in this seminar keynote addresses from: Professor Dame Sally Davies, Chief Medical Officer, Department of Health and Social Care (subject to diary); Professor Alan Johnson, Head of Surveillance, Antimicrobial Resistance Division, National Infection Service, Public Health England; Dr Manica Balasegaram, Executive Director, Global Antibiotic Research and Development Partnership and Gary Cohen, Vice-President, Global Health and President, BD Foundation.

Further confirmed speakers include: James Anderson, Chair, Antibiotic Network, ABPI and Head of Corporate Government Affairs, GSK; Pat Cattini, President, Infection Prevention Society; Professor Ian Feavers,Head of Bacteriology, NIBSC; Richard Griffiths, Chief Executive, British Poultry Council; Cóilín Nunan, Scientific Advisor, Alliance to Save our Antibiotics; Jonathan Pearce, Head of Infections and Immunity, Medical Research Council; Dr Anita Sharma, GP and Clinical Director, Vascular and Medicine Optimisation, NHS Oldham Clinical Commissioning Group and Professor Hilary Thomas, Chief Medical Adviser and Member, Centre of Excellence in Healthcare and Life Sciences, KPMG.

Kevin Hollinrake MP, Co-Chair, All-Party Parliamentary Group on Antibiotics and Lord Trees, Co-Chair, All-Party Parliamentary Group on Antibiotics and Co-Chair, All-Party Parliamentary Group for Animal Welfarehave kindly agreed to chair this seminar.

Additional senior participants are being approached.


This seminar will present an opportunity to engage with key policymakers and other interested parties, and is CPD certified (more details). Places have been reserved by parliamentary pass-holders from the House of Commons Library and officials from the DIT; DHSC; FCO; Government Legal Department and the MHRA. Also due to attend are representatives from Ashford and St Peter’s NHS Foundation Trust; BMJ Publishing Group; Britain Tanzania Society; Cystic Fibrosis Trust; Destiny Pharma; Forte Medical; Hypo-Stream; JVS Products; LifeArc; LSHTM; Medreich; MSD; Oxfam; Oxford Vacmedix; Pfizer; Phico Therapeutics; Public Health Agency; Public Health England; Queen’s University Belfast; Roche Products; Royal Pharmaceutical Society; Royal Veterinary College; Strathclyde Institute of Pharmacy and Biomedical Sciences; SULSA; TranScrip; University of Brighton; University of Kent; University of Leicester; University of Liverpool and University of Oxford.

Press passes have been reserved by representatives from APM Health Europe; Dental Review; POLITICO and Research Fortnight.

Overall, we expect speakers and attendees to be a senior and informed group numbering around 100, including Members of both Houses of Parliament, senior government officials involved in this area of public policy, healthcare professionals, representatives of the healthcare and pharmaceutical industries, academics, charities and user groups, together with reporters from the national and trade media.

Output and About Us

A key output of the seminar will be a transcript of the proceedings, sent out around 12 working days after the event to all attendees and a wider group of Ministers and officials at DHSC, DFID and other government departments; officials and other agencies affected by the issues; and Parliamentarians with a special interest in these areas. It will also be made available more widely. This document will include transcripts of all speeches and questions and answers sessions from the day, along with access to PowerPoint presentations, speakers’ biographies, an attendee list, an agenda, sponsor information, as well as any subsequent press coverage of the day and any articles or comment pieces submitted by delegates. It is made available subject to strict restrictions on public use, similar to those for Select Committee Uncorrected Evidence, and is intended to provide timely information for interested parties who are unable to attend on the day.

All delegates will receive complimentary PDF copies and are invited to contribute to the content.

The Westminster Health Forum and Westminster Food & Nutrition Forum are strictly impartial and cross-party, and draw on the considerable support they receive from within Parliament and Government, and amongst the wider stakeholder community. The Forums have no policy agenda of their own. Forum events are frequently the platform for major policy statements from senior Ministers, regulators and other officials, opposition speakers and senior opinion-formers in industry and interest groups. Events regularly receive prominent coverage in the national and trade media.

Booking arrangements

To book places, please use ouronline booking form.

Once submitted, this will be taken as a confirmed booking and will be subject to our terms and conditions below.

Please pay in advance by credit card on 01344 864796. If advance credit card payment is not possible, please let me know and we may be able to make other arrangements.

Options and charges are as follows:
  • Places at Next steps for combating antimicrobial resistance - funding, prevention and research priorities (including refreshments and PDF copy of the transcripts) are £230 plus VAT;
  • Concessionary rate places for small charities, unfunded individuals and those in similar circumstances are £85 plus VAT. Please be sure to apply for this at the time of booking.
For those who cannot attend:
  • Copies of the briefing document, including full transcripts of all speeches and the questions and comments sessions and further articles from interested parties, will be available approximately 12 days after the event for £95 plus VAT;
  • Concessionary rate: £50 plus VAT.